Aurora Cannabis (ACB) Stock Price, News & Analysis

Company Overview

Aurora Cannabis (NASDAQ:ACB) is a Canada‐based licensed producer of medical and recreational cannabis products. The company cultivates, processes and distributes a wide range of flower, oils, capsules and derivative products under several in-house brands. Aurora operates multiple production facilities in Alberta, including its flagship Aurora Sky and Aurora Sun greenhouses, as well as international cultivation sites and processing facilities in Europe, Latin America and Australia.

Since its founding in 2013, Aurora has grown through a combination of organic investment in controlled-environment facilities and strategic acquisitions of licensed operators. Its vertical integration strategy spans cultivation, research and development, extraction and manufacturing, enabling it to bring pharmaceutical-grade products to market. The company has pursued GMP certification for many of its facilities, underscoring its focus on consistency, quality control and regulatory compliance for medical patients and recreational consumers alike.

In addition to dried flower and oils, Aurora develops edibles, beverages and skincare products designed to meet diverse consumer needs. The company has also established contract cultivation and tolling partnerships, leveraging its production expertise and proprietary genetics to support other licensed producers and research institutions. Aurora’s supply chain network serves markets across North America and Europe, with distribution agreements in Germany, the United Kingdom, Italy and other regulated jurisdictions.

Aurora’s executive team is led by President and Chief Executive Officer Miguel Martin, who joined the company in 2019 after a career in consumer-packaged goods and global operations. The board of directors includes industry veterans and former public-health officials, reflecting Aurora’s dual focus on commercial growth and responsible stewardship. Under this leadership, Aurora continues to refine its operational footprint, expand product offerings and pursue sustainable practices in an evolving cannabis landscape.

Key Stats

• Today's Range: $4.49 to $4.61
• 50-Day Range: $3.91 to $6.15
• 52-Week Range: $3.42 to $7.20
• Volume: 708,073 shs
• Average Volume: 1.57 million shs
• Market Capitalization: $257.16 million
• P/E Ratio: 41.59
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Aurora Cannabis Stock Analysis - MarketRank™

Aurora Cannabis scored higher than 4% of companies evaluated by MarketBeat, and ranked 912th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Aurora Cannabis.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -4.35%

Earnings Growth

Earnings for Aurora Cannabis are expected to decrease by -4.35% in the coming year, from $0.46 to $0.44 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aurora Cannabis is 41.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aurora Cannabis is 41.59, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.75.

Price to Book Value per Share Ratio

Aurora Cannabis has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.98% of the float of Aurora Cannabis has been sold short.

Short Interest Ratio / Days to Cover

Aurora Cannabis has a short interest ratio ("days to cover") of 4.4.

Change versus previous month

Short interest in Aurora Cannabis has recently increased by 2.86%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aurora Cannabis does not currently pay a dividend.

Dividend Growth

Aurora Cannabis does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.98% of the float of Aurora Cannabis has been sold short.

Short Interest Ratio / Days to Cover

Aurora Cannabis has a short interest ratio ("days to cover") of 4.4.

Change versus previous month

Short interest in Aurora Cannabis has recently increased by 2.86%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.12

News Sentiment

Aurora Cannabis has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 3 articles on an average week.

Search Interest

17 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 70% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is a decrease of -44% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Aurora Cannabis is held by insiders.

Percentage Held by Institutions

47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ACB Stock Analysis - Frequently Asked Questions

How have ACB shares performed this year?

Aurora Cannabis' stock was trading at $4.25 on January 1st, 2025. Since then, ACB stock has increased by 7.6% and is now trading at $4.5750.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NASDAQ:ACB) issued its quarterly earnings results on Wednesday, June, 18th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.04. The company earned $63.34 million during the quarter, compared to analyst estimates of $88.85 million. Aurora Cannabis had a trailing twelve-month return on equity of 0.13% and a net margin of 1.32%.
Read the conference call transcript.

When did Aurora Cannabis' stock split?

Aurora Cannabis's stock reverse split on the morning of Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Does Aurora Cannabis have any subsidiaries?

Aurora Cannabis subsidiaries include Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more.

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), Marinus Pharmaceuticals (MRNS) and American Water Works (AWK).

Company Calendar

• Last Earnings: 6/18/2025
• Today: 7/06/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ACB
• Previous Symbol: NYSE:ACB
• CIK: 1683541
• Web: auroramj.com
• Phone: (855) 279-4652
• Fax: N/A
• Employees: 1,130
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): $0.11
• Trailing P/E Ratio: 41.59
• Forward P/E Ratio: 9.95
• P/E Growth: N/A
• Net Income: $1.63 million
• Net Margins: 1.32%
• Pretax Margin: 5.94%
• Return on Equity: 0.13%
• Return on Assets: 0.10%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 4.31
• Quick Ratio: 2.16

Sales & Book Value

• Annual Sales: $246.72 million
• Price / Sales: 1.04
• Cash Flow: $0.62 per share
• Price / Cash Flow: 7.43
• Book Value: $7.78 per share
• Price / Book: 0.59

Miscellaneous

• Outstanding Shares: 56,210,000
• Free Float: 56,208,000
• Market Cap: $257.16 million
• Optionable: Optionable
• Beta: 1.75